The forecasted mortality data for liver malignant neoplasms in the UK shows a steady increase from 2024 to 2028, with yearly values of 4.41k, 4.54k, 4.68k, 4.81k, and 4.94k male deaths, respectively. At the end of 2023, actual mortality stood at 4.41k. The year-on-year growth suggests an increase in mortality rates by approximately 3% annually. The compound annual growth rate (CAGR) over the forecast period (2024-2028) is around 2.8%, indicating a persistent upward trend in liver cancer mortality.
Future trends to watch for include potential impacts from advancements in medical treatment, public health initiatives aimed at liver cancer prevention, and lifestyle changes influencing liver disease prevalence. Close attention to emerging therapies and preventive measures could alter this trajectory.
